Cardiology Inpatient Services

As the name suggests, the Cardiac Critical Care Service cares for critically ill patients with advanced heart and vascular disease who need intensive care and close monitoring. Examples include patients with heart attacks, cardiac arrest, advanced heart failure, dangerously low or high blood pressure, severe infections, and potentially lethal heart rhythm problems.

Our team of cardiology doctors, critical care-trained nurses, and pharmacists work closely with medical, neurological, and surgical providers to deliver comprehensive critical care services to our patients. Zuckerberg San Francisco General Hospital and Trauma Center has a total of 300 inpatient beds with 30 critical care beds that are designed and equipped to address diverse clinical needs like mechanical circulatory and ventilator support, hemodialysis, and invasive monitoring. We are committed to providing high-quality, cost-efficient critical care to our patients.

300

inpatient beds

Our team is also actively involved in training of the next generation of doctors, nurses, and technicians, to ensure that we continue to meet the needs of the Bay Area community in the future. Our faculty provide prompt full-service Cardiology Consult Services to other medical and surgical teams in the hospital. For example, a patient admitted to the trauma service following a car accident may need cardiology input on new heart rhythm problems that may develop after blunt trauma to the chest. Similarly, a patient admitted for pneumonia may develop chest pain and require prompt evaluation for whether this is related to the underlying pneumonia or represents a heart attack. We work closely with physicians and surgeons from other specialties to assist with inpatient workup and treatment, as well in facilitating clinic appointments.

Cardiac Critical Care Service faculty typically admit 5 new patients per day and provide care to 15 follow up patients. Cardiology Consult Service faculty will typically evaluate 3 new patients per day and assess progress on 2 follow up patients.